Hamilton Lane (NASDAQ:HLNE) Releases Quarterly Earnings Results

Hamilton Lane (NASDAQ:HLNE) announced its quarterly earnings results on Tuesday. The company reported $1.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.13 by $0.12, Zacks reports. Hamilton Lane had a return on equity of 35.59% and a net margin of 28.03%. The company had revenue of $168.26 million during the quarter, compared to the consensus estimate of $158.86 million. During the same period in the prior year, the company earned $0.71 earnings per share. The company’s revenue for the quarter was up 34.3% compared to the same quarter last year.

Hamilton Lane Stock Down 0.1 %

NASDAQ HLNE opened at $170.09 on Thursday. The business has a fifty day moving average price of $160.06 and a two-hundred day moving average price of $162.80. The company has a debt-to-equity ratio of 0.24, a current ratio of 3.37 and a quick ratio of 3.37. Hamilton Lane has a fifty-two week low of $103.42 and a fifty-two week high of $203.72. The stock has a market capitalization of $9.43 billion, a PE ratio of 36.76 and a beta of 1.25.

Hamilton Lane Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 4th. Shareholders of record on Friday, March 14th will be given a dividend of $0.49 per share. The ex-dividend date of this dividend is Friday, March 14th. This represents a $1.96 annualized dividend and a yield of 1.15%. Hamilton Lane’s dividend payout ratio is currently 42.52%.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on HLNE. UBS Group increased their price objective on Hamilton Lane from $150.00 to $185.00 and gave the stock a “neutral” rating in a report on Tuesday, October 22nd. Wells Fargo & Company raised their target price on shares of Hamilton Lane from $163.00 to $169.00 and gave the company an “equal weight” rating in a research report on Wednesday. The Goldman Sachs Group downgraded shares of Hamilton Lane from a “neutral” rating to a “sell” rating and set a $139.00 target price for the company. in a research report on Monday, January 6th. Morgan Stanley lifted their price objective on shares of Hamilton Lane from $182.00 to $190.00 and gave the company an “equal weight” rating in a research report on Monday, November 11th. Finally, Oppenheimer raised shares of Hamilton Lane from a “market perform” rating to an “outperform” rating and set a $186.00 target price for the company in a report on Tuesday, January 21st. One analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $173.14.

Hamilton Lane Company Profile

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.